Literature DB >> 22977986

Renal cell carcinoma: a reappraisal.

Chintan Patel1, Asma Ahmed, Pamela Ellsworth.   

Abstract

Surgical treatment of renal cell carcinoma is the gold standard. Nephron-sparing surgery, laparoscopic and robotic surgery and minimally invasive procedures have decreased the morbidity of treatment. Although traditionally resistant to chemotherapy and radiation therapy, advances have been made with immunotherapies. Physicians and nurses caring for patients with renal cell carcinoma should be aware of changes in management and newer therapies for treatment of advanced disease.

Entities:  

Mesh：

Year:  2012        PMID： 22977986

Source DB:  PubMed          Journal:  Urol Nurs        ISSN： 1053-816X


  13 in total

1.  Clinicopathological significance of galectin-1 expression and percentage of galectin-1-expressing T cells in clear-cell renal cell carcinoma.

Authors:  Yajuan Su; Wentao Wang; Yongpeng Xu; Wei Liangjun; Yanjie Wang; Changfu Li; Lichen Teng
Journal:  Can Urol Assoc J       Date:  2018-03-25       Impact factor: 1.862

2.  Identification of miR-7 as an oncogene in renal cell carcinoma.

Authors:  Zuhu Yu; Liangchao Ni; Duqun Chen; Qiang Zhang; Zhengming Su; Yadong Wang; Wenshui Yu; Xionghui Wu; Jiongxian Ye; Shangqi Yang; Yongqing Lai; Xianxin Li
Journal:  J Mol Histol       Date:  2013-06-21       Impact factor: 2.611

3.  Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.

Authors:  Yifan Li; Duqun Chen; L U Jin; Jiaju Liu; Yuchi Li; Zhengming Su; Zhengyu Qi; Min Shi; Zhimao Jiang; Shangqi Yang; Yaoting Gui; Xiangming Mao; Xionghui Wu; Yongqing Lai
Journal:  Oncol Lett       Date:  2015-12-10       Impact factor: 2.967

4.  Zero ischemia robotic-assisted partial nephrectomy in Alberta: Initial results of a novel approach.

Authors:  Ellen Forbes; Douglas Cheung; Adam Kinnaird; Blair St Martin
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

5.  C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation.

Authors:  Yiting Wang; Shuang Liu; Shaoping Tian; Runxuan Du; Tianyu Lin; Xuesong Xiao; Rui Wang; Ruibing Chen; Hua Geng; Saravanan Subramanian; Yuanjie Niu; Yong Wang; Dan Yue
Journal:  Int J Med Sci       Date:  2022-05-09       Impact factor: 3.642

6.  Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.

Authors:  Wesam M Osman; Nermeen S Youssef
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

7.  Fabrication of mAb G250-SPIO molecular magnetic resonance imaging nanoprobe for the specific detection of renal cell carcinoma in vitro.

Authors:  Cailuan Lu; Jingjing Li; Kai Xu; Chun Yang; Jiali Wang; Cuiping Han; Xiaohua Liu
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

8.  Benefit of a second opinion for lung cancer: no metastasis to the kidney but a synchronous primary renal neoplasm.

Authors:  Marleen J Ter Avest; Romane M Schook; Lyan G Koudstaal; Katrien Grünberg; Marinus A Paul; Egbert F Smit; Pieter E Postmus
Journal:  Case Rep Oncol       Date:  2014-02-19

9.  Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro.

Authors:  Lichen Teng; Yongsheng Chen; Yan Cao; Wentao Wang; Yongpeng Xu; Yanjie Wang; Jiayin Lv; Changfu Li; Yajuan Su
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

10.  The long non-coding RNA NEAT1 enhances epithelial-to-mesenchymal transition and chemoresistance via the miR-34a/c-Met axis in renal cell carcinoma.

Authors:  Fei Liu; Na Chen; Yanchun Gong; Ruihai Xiao; Weichao Wang; Zhengyue Pan
Journal:  Oncotarget       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.